Prostate Cancer - Results from #23680

A note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening - Abstract March 6, 2013

Significance of neoadjuvant hormonal therapy in radical retropubic prostatectomy: A retrospective single-surgeon study - Abstract March 6, 2013

Oxidative stress markers in prostate cancer patients after HDR brachytherapy combined with external beam radiation - Abstract March 6, 2013

Echogenicity in transrectal ultrasound is determined by sound speed of prostate tissue components - Abstract March 6, 2013

Health-related quality of life in prostate cancer - Abstract March 6, 2013

Serum antibodies to blood group A predict survival on PROSTVAC-VF - Abstract March 5, 2013

Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer - Abstract March 5, 2013

Hip fractures and pain following proton therapy for management of prostate cancer - Abstract March 5, 2013

Men's preferences for prostate cancer screening: A discrete choice experiment - Abstract March 5, 2013

Does the presence of hypoechoic lesions on transrectal ultrasound suggest a poor prognosis for patients with localized prostate cancer? - Abstract March 5, 2013

Complementary and alternative medicine (CAM) use among men with a history of prostate cancer - Abstract March 5, 2013

Prostate cancer: Is it time to expand the research focus to early-life exposures? - Abstract March 5, 2013

Salvage external beam radiotherapy for recurrent prostate adenocarcinoma after high-intensity focused ultrasound as primary treatment - Abstract March 5, 2013

Salvage radical prostatectomy as management of locally recurrent prostate cancer: Outcomes and complications - Abstract March 4, 2013

The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): A survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer - Abstract March 4, 2013

Ultrasound probe and needle-guide calibration for robotic ultrasound scanning and needle targeting - Abstract March 4, 2013

Prognostic factors for acute toxicity in prostate cancer patients treated with high-dose hypofractionated radiotherapy - Abstract March 4, 2013

Ability of preoperative 3.0-Tesla magnetic resonance imaging to predict the absence of side-specific extracapsular extension of prostate cancer - Abstract March 4, 2013

From bevacizumab to tasquinimod: Angiogenesis as a therapeutic target in prostate cancer - Abstract March 4, 2013

A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons - Abstract March 4, 2013

Page 1185 of 1435